Myriad Genetics
MYGN
MYGN
272 hedge funds and large institutions have $3.4B invested in Myriad Genetics in 2014 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 82 increasing their positions, 105 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
47% less call options, than puts
Call options by funds: $30.5M | Put options by funds: $58.2M
48% less capital invested
Capital invested by funds: $6.54B → $3.4B (-$3.14B)
Holders
272
Holding in Top 10
2
Calls
$30.5M
Puts
$58.2M
Top Buyers
| 1 | +$54.6M | |
| 2 | +$43.8M | |
| 3 | +$36.5M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$23M |
| 5 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$20.2M |
Top Sellers
| 1 | -$2.64B | |
| 2 | -$130M | |
| 3 | -$72.2M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$12.7M |
| 5 |
GAM
Gotham Asset Management
New York
|
-$10.2M |